Recent exceptional negative changes in investment behavior have affected AbbVie Inc (NYSE: ABBV): its longer term price trend turned down, its shorter term price trend turned down, the stock fell on very heavy volume, and negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
AbbVie has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. AbbVie has a neutral Appreciation Score of 58 and a slightly positive Power Rating of 64, with the High Neutral Value Trend Rating the result.
Recent Price Action
AbbVie Inc (NYSE: ABBV) stock closed at $164.99 on 11/15/24 after a decline of -2.7%. Moreover, this decline was accompanied by exceptionally high trading volume at 200% of normal. Relative to the market the stock has been strong over the last nine months but has declined -17.7% during the last week.
Be the first to comment